Of note, the half inhibition concentrations (IC50) of the PROTACs were tens of times lower than that of the BRD4 inhibitor JQ1 (Fig. 2d), suggesting that the BRD4 degraders more significantly impaired the proliferation of the tumour cells than the BRD4 inhibitor. The gene discussed is BRD4; the disease is neoplasm.